Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
This study examined the dose-related efficacy of disulfiram for treating cocaine dependence in methadone-stabilized cocaine dependent participants. Design One hundred sixty-one cocaine-and opioid-dependent volunteers were entered into a 14-week, double blind, randomized, placebo-controlled clinical trial at two sites. Methods Participants were stabilized on methadone during weeks 1–2 and received disulfiram at 0, 62.5, 125 or 250 mg/day during weeks 3–14. All participants also received weekly cognitive behavioral therapy. Thrice-weekly urine samples and weekly self-reported drug use assessments were obtained. Results Baseline subject characteristics, retention and drug use did not differ across groups. Outcome analyses were performed on those who participated beyond week 2. Opioid positive urine samples and self-reported opioid use did not differ by treatment group. The prevalence of alcohol use was low prior to and during the trial and did not differ by treatment group. Cocaine-positive urines increased over time in the 62.5 and 125 mg disulfiram groups and decreased over time in the 250 mg disulfiram and placebo groups (p<0.0001). Self-reported cocaine use increased in the 125 mg disulfiram group relative to the other three treatment groups (p=0.04). Conclusions Disulfiram may be contraindicated for cocaine dependence at doses less than 250 mg/day. Whether disulfiram at higher doses is efficacious in reducing cocaine use in dually cocaine and opioid dependent individuals needs to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287
Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter
Pacholczyk, T., Blakely, R. D., & Amara, S. G. (1991) · Nature · doi:10.1038/350350a0 · Cited by 933 · cited 1×
“Dopamine is avidly transported by both dopamine and noreinephrine transporters and cocaine blocks the activity of these ransporters (Carboni et al., 1990; Pacholczyk et al., 1991; Tanda et l., 1997), thereby enhancing the action of dopamine.”
Properties of the urn randomization in clinical trials
Wei, L. J., & Lachin, J. M. (1988) · Controlled Clinical Trials · doi:10.1016/0197-2456(88)90048-7 · Cited by 308
Reliability and validity of the cocaine selective severity assessment
Kampman, K. M., Volpicelli, J. R., Mcginnis, D. E., Alterman, A. I., Weinrieb, R. M., D’Angelo, L., & Epperson, L. E. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00011-2 · Cited by 272
Grabowski, J., Rhoades, H., Stotts, A., Cowan, K., Kopecky, C., Dougherty, A., Moeller, F. G., Hassan, S., & Schmitz, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300392 · Cited by 185
Research works printed but not linked: 55
- Baker, 2007, Disulfiram effects on responses to intravenous cocaine administration, Drug Alcohol Depend., 87, 202, 10.1016/j.drugalcdep.2006.08.016 · DOI
- Black, 1987, The effect of increased cocaine use on drug treatment, Addict. Behav., 12, 289, 10.1016/0306-4603(87)90042-6 · DOI
- Bovasso, 2003, The long-term outcomes of drug use by methadone maintenance patients, J. Behav. Health Serv. Res., 30, 290, 10.1007/BF02287318 · DOI
- Bryk, 1987, Application if hierarchical linear models to assessing change, Psychol. Bull., 101, 147, 10.1037/0033-2909.101.1.147 · doi:10.1037/0033-2909.101.1.147 · Paper page
- Bux, 1995, Cocaine use and HIV risk behavior in methadone maintenance patients, Drug Alcohol Depend., 37, 29, 10.1016/0376-8716(94)01058-S · DOI
- Carboni, 1990, Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals, J. Neurochem., 55, 1067, 10.1111/j.1471-4159.1990.tb04599.x · DOI · Paper page
- Carroll, 2004, Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial, Arch. Gen. Psychiatry, 61, 264, 10.1001/archpsyc.61.3.264 · DOI · Paper page
- Carroll, 1998, Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram, Addiction, 93, 713, 10.1046/j.1360-0443.1998.9357137.x · DOI · Paper page
- Carroll, 1993, Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic significance, J. Stud. Alcohol, 54, 199, 10.15288/jsa.1993.54.199 · DOI · Paper page
- Compton, 1995, Results of the NIDA treatment demonstration grants’ cocaine workgroup: characteristics of cocaine users and HIV risk behaviors, Drug Alcohol Depend., 37, 1, 10.1016/0376-8716(94)01061-O · DOI
- Condelli, 1991, Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions, J. Subst. Abuse Treat., 8, 203, 10.1016/0740-5472(91)90040-H · DOI
- Cubells, 2004, DBH genotype in disulfiram treatment for cocaine dependence, Neuropsychopharmacology, 29, S72
- Cubells, 2004, Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology, Psychopharmacology (Berl.), 174, 463, 10.1007/s00213-004-1840-8 · DOI · Paper page
- de Lima, 2002, Pharmacological treatment of cocaine dependence: a systematic review, Addiction, 97, 931, 10.1046/j.1360-0443.2002.00209.x · DOI · Paper page
- Disney, 2005, Prevalence and correlates of cocaine physical dependence subtypes using the DSM-IV in outpatients receiving opioid agonist medication, Drug Alcohol Depend., 79, 23, 10.1016/j.drugalcdep.2004.11.012 · DOI
- Dobler-Mikola, 2005, Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment, J. Subst. Abuse Treat., 29, 259, 10.1016/j.jsat.2005.08.002 · DOI
- El-Bassel, 2004, Physical and sexual intimate partner violence among women in methadone maintenance treatment, Psychol. Addict. Behav., 18, 180, 10.1037/0893-164X.18.2.180 · DOI · Paper page
- Gawin, 1986, Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: Clinical observations, Arch. Gen. Psychiatry, 43, 107, 10.1001/archpsyc.1986.01800020013003 · DOI · Paper page
- George, 2000, Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial, Biol. Psychiatry, 47, 1080, 10.1016/S0006-3223(99)00310-8 · DOI · Paper page
- Gibbons, 1993, Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset, Arch. Gen. Psychiatry, 50, 739, 10.1001/archpsyc.1993.01820210073009 · DOI · Paper page
- Grella, 1995, Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients, Drug Alcohol Depend., 37, 15, 10.1016/0376-8716(94)01059-T · DOI
- Haley, 1979, Disulfiram (tetraethylthioperoxydicarbonic diamide): a reappraisal of its toxicity and therapeutic application, Drug Metab. Rev., 9, 319, 10.3109/03602537908993897 · DOI
- Hameedi, 1995, Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans, Biol. Psychiatry, 37, 560, 10.1016/0006-3223(94)00361-6 · DOI
- Hartell, 1995, Heroin use during methadone maintenance treatment: the importance of methadone doe and cocaine use, Am. J. Publ. Health, 85, 83, 10.2105/AJPH.85.1.83 · DOI · Paper page
- Higgins, 1996, Alcohol pretreatment increases preference for cocaine over monetary reinforcement, Psychopharmacology, 123, 1, 10.1007/BF02246274 · DOI
- Honjo, 1969, Inhibition of drug demethylation by disulfiram in vivo and in vitro, Biochem. Pharmacol., 18, 2681, 10.1016/0006-2952(69)90201-9 · DOI
- Hunt, 1986, The costly bonus: cocaine related crime among methadone treatment clients, Adv. Alcohol Subst. Abuse, 6, 107, 10.1300/J251v06n02_08 · DOI
- Jatlow, 1991, Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion, Life Sci., 48, 1787, 10.1016/0024-3205(91)90217-Y · DOI · Paper page
- Karamanakos, 2001, Differentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolism, Pharmacol. Toxicol., 88, 106, 10.1034/j.1600-0773.2001.088002106.x · DOI · Paper page
- King, 2001, Influence of antisocial personality subtypes on drug abuse treatment response, J. Nerv. Ment. Dis., 189, 593, 10.1097/00005053-200109000-00004 · DOI
- Kosten, 2003, Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained paintents, Drug Alcohol Depend., 70, 315, 10.1016/S0376-8716(03)00032-2 · DOI
- Kosten, 1988, Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up, J. Nerv. Ment. Dis., 176, 176, 10.1097/00005053-198803000-00006 · DOI · Paper page
- Ledgerwood, 2002, Relationship between problem gambling and substance use in a methadone maintenance population, Addict. Behav., 27, 483, 10.1016/S0306-4603(01)00187-3 · DOI
- Lima, 2002, Carbamazepine for cocaine dependence, Cochrane Database Syst. Rev., 10.1002/14651858.CD003727.pub2 · DOI
- Lima, 2003, Antidepressants for cocaine dependence, Cochrane Database Syst. Rev., 10.1002/14651858.CD002950 · DOI · Paper page
- MacGowan, 1997, Factors associated with client-reported HIV infection among clients entering methadone treatment, AIDS Educ. Prev., 9, 205
- Magura, 1998, Pre- and in-treatment predictors of retention in methadone treatment using survival analysis, Addiction, 93, 51, 10.1046/j.1360-0443.1998.931516.x · DOI · Paper page
- Magura, 2002, Treating cocaine-using methadone patients: predictors of outcomes in a psychosocial clinical trial, Subst. Use Misuse, 37, 1927, 10.1081/JA-120016225 · DOI · Paper page
- McCance-Katz, 1998, Chronic disulfiram treatment effects on intranasal cocaine administration: initial results, Biol. Psychiatry, 43, 540, 10.1016/S0006-3223(97)00506-4 · DOI · Paper page
- McCance-Katz, 1998, Disulfiram effects on acute cocaine administration, Drug Alcohol Depend., 52, 27, 10.1016/S0376-8716(98)00050-7 · DOI · Paper page
- McCance-Katz, 1993, Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene, Psychopharmacology (Berl.), 111, 39, 10.1007/BF02257405 · DOI · Paper page
- McCance, 1995, Cocaethylene: pharmacology, physiology and behavioral effects in humans, J. Pharmacol. Exp. Ther., 274, 215, 10.1016/S0022-3565(25)10557-0 · DOI · Paper page
- McLellan, 1980, An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index, J. Nerv. Ment. Dis., 168, 26, 10.1097/00005053-198001000-00006 · DOI · Paper page
- Meandzija, 1994, HIV infection and cocaine use in methadone maintained and untreated intravenous drug users, Drug Alcohol Depend., 36, 109, 10.1016/0376-8716(94)90092-2 · DOI
- Mulvaney, 1999, Cocaine abstinence symptomatology and treatment attrition, J. Subst. Abuse Treat., 16, 129, 10.1016/S0740-5472(98)00017-8 · DOI · Paper page
- Oliveto, 2005, Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients, Drug Alcohol Depend., 79, 157, 10.1016/j.drugalcdep.2005.01.007 · DOI
- Pani, 2010, Disulfiram for the treatment of cocaine dependence, Cochrane Database Syst. Rev., 10.1002/14651858.CD007024.pub2 · DOI · Paper page
- Petrakis, 2000, Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts, Addiction, 95, 219, 10.1046/j.1360-0443.2000.9522198.x · DOI · Paper page
- Soares, 2004, Dopamine agonists for cocaine dependence, Cochrane Database Syst. Rev.
- Stanley, 1997, Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase, Br. J. Pharmacol., 121, 1803, 10.1038/sj.bjp.0701315 · DOI · Paper page
- Stewart, 1979, Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases, Clin. Pharmacol. Ther., 25, 464, 10.1002/cpt1979254464 · DOI · Paper page
- Tanda, 1997, Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine, Eur. J. Neurosci., 9, 2077, 10.1111/j.1460-9568.1997.tb01375.x · DOI · Paper page
- Williamson, 2006, The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence, Drug Alcohol Depend., 81, 293, 10.1016/j.drugalcdep.2005.08.010 · DOI
- Wolf, 2004, Methadone-related deaths in Palm Beach County, J. Forensic Sci., 49, 375, 10.1520/JFS2003221 · DOI
- Wright, 1990, Disulfiram treatment of alcoholism, Am. J. Med., 88, 647, 10.1016/0002-9343(90)90534-K · DOI · Paper page
Cited by
Retention in medication-assisted treatment for opiate dependence: A systematic review
Timko, C., Schultz, N. R., Cucciare, M. A., Vittorio, L., & Garrison-Diehn, C. (2016) · Journal of Addictive Diseases · doi:10.1080/10550887.2016.1100960 · Cited by 489
Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis
Skinner, M. D., Lahmek, P., Pham, H., & Aubin, H.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087366 · Cited by 347
“Because we did not obtain a response from the fifth author [30], we were unable to include their trial.”
BackgroundLingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
“5 mg or 125 mg daily) and decreasing cocaine use only in patients given high-dose disulfiram (250 mg; Oliveto et al., 2011) (Ib).”
BackgroundBentzley, B. S., Han, S. S., Neuner, S., Humphreys, K., Kampman, K. M., & Halpern, C. H. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.8049 · Cited by 161
Pharmacotherapy for Cocaine Use Disorder—a Systematic Review and Meta-analysis
Chan, B., Kondo, K., Freeman, M., Ayers, C., Montgomery, J., & Kansagara, D. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05074-8 · Cited by 150
Metadata
- Authors
- Oliveto, A., Poling, J., Mancino, M. J., Feldman, Z., Cubells, J. F., Pruzinsky, R., Gonsai, K., Cargile, C., Sofuoglu, M., Chopra, M. P., Gonzalez-Haddad, G., Carroll, K. M., & Kosten, T. R.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 113
- Issue
- 2-3
- Pages
- 184-191
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W1990473903
- Cited by
- 70
- References
- 5
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. https://app.cochat.ai/papers/10.1016/j.drugalcdep.2010.07.022
- The paper
- Oliveto, A., Poling, J., Mancino, M. J., Feldman, Z., Cubells, J. F., Pruzinsky, R., Gonsai, K., Cargile, C., Sofuoglu, M., Chopra, M. P., Gonzalez-Haddad, G., Carroll, K. M., & Kosten, T. R. (2011). Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2010.07.022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.